Literature DB >> 9278524

Studies on the role of fibroblast growth factor signaling in neurogenesis using conjugated/aged animal caps and dorsal ectoderm-grafted embryos.

R H Xu1, J Kim, M Taira, D Sredni, H Kung.   

Abstract

Basic fibroblast growth factor (bFGF) has been shown to induce neural fate in dissociated animal cap (AC) cells or in AC explants cultured in low calcium and magnesium concentrations. However, long-term disclosure of the cap may cause diffusion of the secreted molecule bone morphogenetic protein 4 (BMP-4), a neural inhibitor present in the AC. This may contribute to the subsequent neurogenesis induced by bFGF. Here we used conjugated and aged blastula AC to avoid diffusion of endogenous molecules from the AC. Unlike noggin, bFGF failed to induce neural tissue in this system. However, it enhanced neuralization elicited by a dominant negative BMP receptor (DN-BR) that inhibits the BMP-4 signaling. Posterior neural markers were turned on by bFGF in AC expressing DN-BR or chordin. Blocking the endogenous FGF signal with a dominant negative FGF receptor (XFD) mainly inhibited development of posterior neural tissue in neuralized ACs. These in vitro studies were confirmed in vivo in embryos grafted with XFD-expressing ACs in the place of neuroectoderm. Expression of some regional neural markers was inhibited, although markers for muscle and posterior notochord were still detectable in the grafted embryos, suggesting that XFD specifically affected neurogenesis but not the dorsal mesoderm. The use of these in vitro and in vivo model systems provides new evidence that FGF, although unable to initiate neurogenesis on its own, is required for neural induction as well as for posteriorization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278524      PMCID: PMC6573287     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  48 in total

1.  Involvement of p21ras in Xenopus mesoderm induction.

Authors:  M Whitman; D A Melton
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

2.  The two-gradient hypothesis in primary induction. The combined effect of two types of inductors mixed in different ratios.

Authors:  L SAXEN; S TOIVONEN
Journal:  J Embryol Exp Morphol       Date:  1961-09

3.  Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes.

Authors:  Y Sasai; B Lu; H Steinbeisser; D Geissert; L K Gont; E M De Robertis
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

4.  The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4.

Authors:  L B Zimmerman; J M De Jesús-Escobar; R M Harland
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

5.  Involvement of Ras/Raf/AP-1 in BMP-4 signaling during Xenopus embryonic development.

Authors:  R H Xu; Z Dong; M Maeno; J Kim; A Suzuki; N Ueno; D Sredni; N H Colburn; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

6.  Induction of epidermis and inhibition of neural fate by Bmp-4.

Authors:  P A Wilson; A Hemmati-Brivanlou
Journal:  Nature       Date:  1995-07-27       Impact factor: 49.962

7.  Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction.

Authors:  S H Hawley; K Wünnenberg-Stapleton; C Hashimoto; M N Laurent; T Watabe; B W Blumberg; K W Cho
Journal:  Genes Dev       Date:  1995-12-01       Impact factor: 11.361

8.  Expression of Xenopus N-CAM RNA in ectoderm is an early response to neural induction.

Authors:  C R Kintner; D A Melton
Journal:  Development       Date:  1987-03       Impact factor: 6.868

9.  Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation.

Authors:  K L Kroll; E Amaya
Journal:  Development       Date:  1996-10       Impact factor: 6.868

10.  Fate map for the 32-cell stage of Xenopus laevis.

Authors:  L Dale; J M Slack
Journal:  Development       Date:  1987-04       Impact factor: 6.868

View more
  7 in total

Review 1.  Evolution of vertebrate forebrain development: how many different mechanisms?

Authors:  A C Foley; C D Stern
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

Review 2.  Deriving excitatory neurons of the neocortex from pluripotent stem cells.

Authors:  David V Hansen; John L R Rubenstein; Arnold R Kriegstein
Journal:  Neuron       Date:  2011-05-26       Impact factor: 17.173

3.  Noggin and basic FGF were implicated in forebrain fate and caudal fate, respectively, of the neural tube-like structures emerging in mouse ES cell culture.

Authors:  Shunmei Chiba; Manae S Kurokawa; Hideshi Yoshikawa; Ritsuko Ikeda; Mitsuhiro Takeno; Mamoru Tadokoro; Hiroaki Sekino; Takuo Hashimoto; Noboru Suzuki
Journal:  Exp Brain Res       Date:  2005-02-10       Impact factor: 1.972

4.  Specification of region-specific neurons including forebrain glutamatergic neurons from human induced pluripotent stem cells.

Authors:  Hui Zeng; Min Guo; Kristen Martins-Taylor; Xiaofang Wang; Zheng Zhang; Jung Woo Park; Shuning Zhan; Mark S Kronenberg; Alexander Lichtler; Hui-Xia Liu; Fang-Ping Chen; Lixia Yue; Xue-Jun Li; Ren-He Xu
Journal:  PLoS One       Date:  2010-07-29       Impact factor: 3.240

Review 5.  Role of BMP, FGF, calcium signaling, and Zic proteins in vertebrate neuroectodermal differentiation.

Authors:  Jun Aruga; Katsuhiko Mikoshiba
Journal:  Neurochem Res       Date:  2011-02-19       Impact factor: 3.996

6.  xCyp26c Induced by Inhibition of BMP Signaling Is Involved in Anterior-Posterior Neural Patterning of Xenopus laevis.

Authors:  Saet-Byeol Yu; Zobia Umair; Shiv Kumar; Unjoo Lee; Seung-Hwan Lee; Jong-Il Kim; SungChan Kim; Jae-Bong Park; Jae-Yong Lee; Jaebong Kim
Journal:  Mol Cells       Date:  2016-02-29       Impact factor: 5.034

7.  FGF mediated MAPK and PI3K/Akt Signals make distinct contributions to pluripotency and the establishment of Neural Crest.

Authors:  Lauren Geary; Carole LaBonne
Journal:  Elife       Date:  2018-01-19       Impact factor: 8.140

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.